InvestorsHub Logo
Followers 18
Posts 1022
Boards Moderated 0
Alias Born 12/18/2020

Re: samsamsamiam post# 2318

Saturday, 03/06/2021 3:12:17 PM

Saturday, March 06, 2021 3:12:17 PM

Post# of 2447
With in your link are you citing IMMB is still suspended?

Item thirteen says different:

13
attach to its answering brief is granted. We have determined to resolve the petition without
The Division’s unopposed motion for leave to file exhibits that it inadvertently failed to
scheduling an in-person hearing. See Rule of Practice 550(b), 17 C.F.R. § 201.550(b) (stating (footnote continued . . . ) trading suspension is no longer in effect, we have the authority to resolve Immunotech’s petition on the merits.14 Among other things, our decision to address the substance of Immunotech’s arguments promotes the development of the record in the event Immunotech seeks judicial review.

The SEC filed the suspension citing the claim is misleading.

At that time the SEC had no clue about this company or it’s manufacturing of the ImmunH.

Which would make sense if you are a start up and you make a claim in regard of having a medicine that can fight Ebola head on, that would draw a lot of suspicion.